1 오승준, "여성 복압성요실금 환자에서 한국어판 Incontinence Quality of Life 설문도구의 타당도 및 신뢰도에 관한 정신측정학적 특성" 대한배뇨장애요실금학회 13 (13): 51-60, 2009
2 김동석, "성기능 평가를 위한 DAN-PSS의 국문번역의 타당성과 신뢰도" 대한비뇨의학회 44 (44): 871-875, 2003
3 이용석, "배뇨장애 환자 삶의 질 측정도구 한국어판 ‘퀄리빈 설문’의 언어 타당도" 대한재활의학회 34 (34): 524-543, 2010
4 Koeveringe GA Van, "models and proposals for future research" 33 : 591-596, 2014
5 Irwin DE, "and other lower urinary tract symptoms in five countries : results of the EPIC study" 50 : 1306-1315, 2006
6 Irwin DE, "Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction" 108 : 1132-1139, 2011
7 Lim R, "Which outcome measures should be used in stress urinary incontinence trials?" 121 : 805-810, 2018
8 Cardozo L, "Validation of the urgency perception scale" 95 : 591-596, 2005
9 Lee KS, "Urinary urgency outcomes after propiverine treatment for an overactive bladder: the “propiverine study on overactive bladder including urgency data”" 105 : 1565-1570, 2010
10 Oh SJ, "Translation and linguistic validation of Korean version of the incontinence quality of life(I-QoL)instrument" 6 : 10-23, 2002
11 Oh SJ, "Translation and linguistic validation of Korean version of the bristol female lower urinary tract symptom instrument" 8 : 89-113, 2004
12 조성용, "Translation and Linguistic Validation of the Korean Version of the “Benefit, Satisfaction, and Willingness to Continue” Questionnaire for Patients With Overactive Bladder" 대한배뇨장애요실금학회 20 (20): 255-259, 2016
13 이하나, "Translation and Linguistic Validation of the Korean Version of the Treatment Satisfaction Visual Analogue Scale and the Overactive Bladder Satisfaction With Treatment Questionnaire" 대한배뇨장애요실금학회 21 (21): 309-319, 2017
14 손환철, "Translation and Linguistic Validation of the Korean Version of the Pelvic Pain and Urgency/Frequency Patient Symptom Scale" 대한배뇨장애요실금학회 14 (14): 112-121, 2010
15 Acquadro C, "Translating overactive bladder questionnaires in 14 languages" 67 : 536-540, 2006
16 Welk B, "The validity and reliability of the neurogenic bladder symptom score" 2-7, 2014
17 Brokelman RBG, "The validation of the visual analogue scale for patient satisfaction after total hip arthroplasty" 3 : 101-105, 2012
18 Coyne KS, "The validation of the patient perception of bladder condition(PPBC) : a single-item global measure for patients with overactive bladder" 49 : 1079-1086, 2006
19 Pleil AM, "The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue - The BSW" 8 (8): S25-S34, 2005
20 Abrams P, "The standardisation of terminology of lower urinary tract function : report from the standardisation sub-committee of the international continence society" 187 : 116-126, 2002
21 Coyne KS, "The prevalence of lower urinary tract symptoms (LUTS)in the USA, the UK and Sweden: results from the epidemiology of LUTS (EpiLUTS) study" 104 : 352-360, 2009
22 Minassian VA, "The interaction of stress and urgency urinary incontinence and its effect on quality of life" 26 : 269-276, 2014
23 Robertson C, "The impact of lower urinary tract symptoms and comorbidities on quality of life : the BACH and UREPIK studies" 99 : 347-354, 2007
24 Berry SJ, "The development of human benign prostatic hyperplasia with age" 132 : 474-479, 1984
25 Jackson S, "The bristol female lower urinary tract symptoms questionnaire : development and psychometric testing" 77 : 805-812, 1996
26 Donovan J, "The ICS-‘BPH’ Study : the psychometric validity and realibility of ICS male questionnaire" 77 : 554-562, 1996
27 Mokkink LB, "The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments : an international Delphi study" 19 : 539-549, 2010
28 Homma Y, "Symptom severity and patient perceptions in overactive bladder: how are they related?" 104 : 968-972, 2009
29 Homma Y, "Symptom assessment tool for overactive bladder syndromeoveractive bladder symptom score" 68 : 318-323, 2006
30 Jeong SJ, "Reproducibility study of overactive bladder symptom score questionnaire and its response to treatment(RESORT)in Korean population with overactive bladder symptoms" 23 : 285-292, 2014
31 Okamura K, "Reliability and validity of the King’s Health Questionnaire for lower urinary tract symptoms in both genders" 103 : 1673-1678, 2009
32 Barry MJ, "Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia" 150 : 351-358, 1993
33 Edwards P, "Questionnaires in clinical trials : guidelines for optimal design and administration" 11 : 1-8, 2010
34 Bushnell DM, "Quality of life of women with urinary incontinence : cross-cultural performance of 15 language versions of the I-QOL" 14 : 1901-1913, 2005
35 Wagner TH, "Quality of life of persons with urinary incontinence : development of a new measure" 47 : 67-71, 1996
36 Uren AD, "Qualitative exploration of the patient experience of underactive bladder" 72 : 402-407, 2017
37 Coyne K, "Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire : the OAB-q" 11 : 563-574, 2002
38 Oh SJ, "Psychometric properties of the Korean version of the King’s health questionnaire in women with stress urinary incontinence" 9 : 115-123, 2005
39 오승준, "Psychometric Properties of the Korean Version of the Overactive Bladder Questionnaire (OAB-q) in a Korean Population" 대한배뇨장애요실금학회 16 (16): 77-85, 2012
40 Lee JA, "Problems translating a questionnaire in a cross-cultural setting" 41 : 187-194, 1999
41 Wild D, "Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes(PRO)measures : report of the ISPOR task force for translation and cultural adaptation" 8 : 94-104, 2005
42 정성진, "Prevalence and Clinical Features of Detrusor Underactivity among Elderly with Lower Urinary Tract Symptoms: A Comparison between Men and Women" 대한비뇨의학회 53 (53): 342-348, 2012
43 Vandoninck V, "Posterior tibial nerve stimulation in the treatment of urge incontinence" 22 : 17-23, 2003
44 Black N, "Patient reported outcome measures could help transform healthcare" 346 : 1-5, 2013
45 Gulur DM, "Management of overactive bladder" 7 : 572-582, 2010
46 강순호, "Linguistic Validation of the Intermittent Self-catheterization Questionnaire for Patients With Neurogenic Bladder Who Perform Intermittent Catheterization for Voiding Dysfunction" 대한배뇨장애요실금학회 23 (23): 75-85, 2019
47 정성진, "Korean Version of the Overactive Bladder Symptom Score Questionnaire: Translation and Linguistic Validation" 대한배뇨장애요실금학회 15 (15): 135-142, 2011
48 Seung-Ee Kim, "Korean Translation and Linguistic Validation of Urgency and Overactive Bladder Questionnaires" 대한배뇨장애요실금학회 24 (24): 66-76, 2020
49 오승준, "King's Health Questionnaire의 한국어 번역 및 번역본의 언어 타당도" 대한비뇨의학회 46 (46): 438-450, 2005
50 Kim M, "Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson’s disease" 21 : 205-210, 2015
51 Avery K, "ICIQ : a brief and robust measure for evaluating the symptoms and impact of urinary incontinence" 23 : 322-330, 2004
52 Mota RL, "Female urinary incontinence and sexuality" 43 : 20-28, 2017
53 Barry MJ, "Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia" 58 : 25-32, 2001
54 Lokeshwar SD, "Epidemiology and treatment modalities for the management of benign prostatic hyperplasia" 8 : 529-539, 2019
55 Gratzke C, "EAU guidelines on the assessment of nonneurogenic male lower urinary tract symptoms including benign prostatic obstruction" 67 : 1099-1109, 2015
56 Tarcan T, "Do the definitions of the underactive bladder and detrusor underactivity help in managing patients : International Consultation on Incontinence Research Society(ICI-RS)Think Tank 2017" 37 : S60-8, 2018
57 Deborah J. Lightner, "Diagnosis and treatment of overactive bladder(non-neurogenic)in adults : AUA/SUFU guideline amendment 2019" 202 : 558-563, 2019
58 Bright E, "Developing and validating the international consultation on incontinence questionnaire bladder diary" 66 : 294-300, 2014
59 Cook DA, "Current concepts in validity and reliability for psychometric instruments : theory and application 2006" 119 : 166.e7-166.e16, 2006
60 Gacci M, "Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia" 60 : 809-825, 2011
61 Yalla SV, "Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism" 153 : 674-680, 1995
62 Notte SM, "Content validity and test-retest reliability of patient perception of intensity of urgency scale(PPIUS)for overactive bladder" 12 : 1-, 2012
63 김성한, "Comparison of Voiding Questionnaires Between Female Interstitial Cystitis and Female Idiopathic Overactive Bladder" 대한배뇨장애요실금학회 14 (14): 86-92, 2010
64 Chughtai B, "Benign prostatic hyperplasia" 2 : 1-15, 2016
65 Coyne KS, "An overactive bladder symptom and health-related quality of life short-form : validation of the OAB-q SF" 34 : 255-263, 2015
66 Haylen BT, "An International Urogynecological Association(IUGA)/International Continence Society(ICS)joint report on the terminology for female pelvic floor dysfunction" 21 : 5-26, 2010
67 Gajewski JB, "An International Continence Society(ICS)report on the terminology for adult neurogenic lower urinary tract dysfunction(ANLUTD)" 37 : 1152-1161, 2018
68 Kennelly M, "Adult neurogenic lower urinary tract dysfunction and intermittent catheterisation in a com-munity setting : risk factors model for urinary tract infections" 2019 : 2757862-, 2019
69 Nixon A, "A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials" 174 : 604-607, 2005
70 Brookes ST, "A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire : data from a randomized controlled trial of surgery for women with stress incontinence" 191 : 73-82, 2004
71 Kelleher CJ, "A new questionnaire to assess the quality of life of urinary incontinent women" 104 : 1374-1379, 1997
72 Chua ME, "A critical review of recent clinical practice guidelines on the diagnosis and treatment of non-neurogenic male lower urinary tract symptoms" 9 : E463-E470, 2015